XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Measurements The following table summarizes our investments and liabilities that are recognized in our unaudited condensed consolidated balance sheets using fair value measurements determined based on the differing levels of inputs. This table excludes investments held by the consolidated sponsored investment products which are presented separately on our unaudited condensed consolidated balance sheets and are detailed in Note 5.
3/31/202312/31/2022
(in millions)
Level 1
Level 2
Level 3
Level 1
Level 2
Level 3
T. Rowe Price investment products
Cash equivalents held in money market funds1,678.9 $— $— $1,412.0 $— $— 
Discretionary investments244.2 — — 242.0 — — 
Seed capital206.5 42.7 — 161.0 34.1 — 
Supplemental savings plan liability economic hedges786.7 — — 760.7 — — 
Other investments.6 — — .6 .1 — 
Investments in affiliated collateralized loan obligations— 7.2 — — 6.4 — 
Total$2,916.9 $49.9 $— $2,576.3 $40.6 $— 
Contingent consideration liability$— $— $46.2 $— $— $95.8 
Schedule of Change in Contingent Consideration Liability
The change in the contingent consideration liability measured at fair value for which we used Level 3 inputs to determine fair value is as follows:

Contingent Consideration Liability
Three months ended
(in millions)3/31/20233/31/2022
Balance at beginning of period$95.8 $306.3 
  Measurement period adjustment— (49.3)
  Unrealized gains, included in earnings(49.6)(45.5)
Balance at end of period$46.2 $211.5